Medovex Corp Analysis

Medovex Corp is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Medovex Corp otc analysis is to determine its intrinsic value, which is an estimate of what Medovex Corp is worth, separate from its market price. There are two main types of Medovex Corp's stock analysis: fundamental analysis and technical analysis.
The Medovex Corp otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Medovex OTC Stock Analysis Notes

About 26.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.05. Medovex Corp had not issued any dividends in recent years. The entity had 1:1000 split on the 13th of June 2022. H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. H CYTE operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.The quote for Medovex Corp is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Medovex Corp call Michael Yurkowsky at 888 664 2983 or check out https://www.hcyte.com.

Medovex Corp Investment Alerts

Medovex Corp is not yet fully synchronised with the market data
Medovex Corp has some characteristics of a very speculative penny stock
Medovex Corp has a very high chance of going through financial distress in the upcoming years
Medovex Corp currently holds 3.88 M in liabilities with Debt to Equity (D/E) ratio of 2.61, implying the company greatly relies on financing operations through barrowing. Medovex Corp has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Medovex Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Medovex Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medovex Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medovex to invest in growth at high rates of return. When we think about Medovex Corp's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.61 M. Net Loss for the year was (4.8 M) with profit before overhead, payroll, taxes, and interest of 906.81 K.
Medovex Corp currently holds about 45.88 K in cash with (4.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Roughly 26.0% of Medovex Corp shares are held by company insiders

Medovex Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.06 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medovex Corp's market, we take the total number of its shares issued and multiply it by Medovex Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Medovex Corp Outstanding Bonds

Medovex Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medovex Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medovex bonds can be classified according to their maturity, which is the date when Medovex Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Medovex Corp to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Dashboard Now

   

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments
All  Next Launch Module
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Medovex OTC Stock

If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device